What is Immunome's software and technology licenses, net?

Immunome (IMNM) reported software and technology licenses, net of $5.36M in Q1 2026.

How has Immunome's software and technology licenses, net changed year-over-year?

Immunome's software and technology licenses, net increased by 23.4% year-over-year, from $4.35M to $5.36M.

What is the long-term trend for Immunome's software and technology licenses, net?

Over 2 years (2023 to 2025), Immunome's software and technology licenses, net has grown at a 577.3% compound annual growth rate (CAGR), from $100K to $4.59M.

Immunome IMNM Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

PfizerPFE

——

Arcus BiosciencesRCUS

——

Nuvation BioNUVB

——

ArriVent BioPharma, Inc.AVBP

——

Summit TherapeuticsSMMT

——

Immunovant, Inc.IMVT

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's software and technology licenses, net?: Immunome (IMNM) reported software and technology licenses, net of $5.36M in Q1 2026.
How has Immunome's software and technology licenses, net changed year-over-year?: Immunome's software and technology licenses, net increased by 23.4% year-over-year, from $4.35M to $5.36M.
What is the long-term trend for Immunome's software and technology licenses, net?: Over 2 years (2023 to 2025), Immunome's software and technology licenses, net has grown at a 577.3% compound annual growth rate (CAGR), from $100K to $4.59M.